American Century Companies’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Other funds holding CSTL
RI
SPPAM
American Century Companies's CSTL Position: Q2 2026 in Review
American Century Companies reduced its Castle Biosciences (CSTL) stake by 17% in Q2 2026, selling an estimated $305K and leaving 65,413 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2281.
American Century Companies first reported a position in CSTL in Q4 2020 and has held it in 15 quarters since. The position peaked at $3.03M in Q4 2025. 167 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.
- American Century Companies held 65,413 shares of Castle Biosciences worth $1.56M as of Q2 2026.
- American Century Companies sold 13,694 Castle Biosciences shares in Q2 2026, an estimated $305K.
- Castle Biosciences made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2281 holding.
- American Century Companies first reported a position in Castle Biosciences in Q4 2020 and has held it in 15 quarters since.
- American Century Companies's Castle Biosciences position peaked at $3.03M in Q4 2025.
- 167 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.